Vivos (RDGL) Change in Accured Expenses (2010 - 2025)
Vivos (RDGL) posted Change in Accured Expenses of -$20221.0 for Q4 2025, down 224.55% sequentially from $16235.0 in Q3 2025, and down 154.08% YoY from $37389.0 in Q4 2024.
Vivos (RDGL) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Vivos has reported Change in Accured Expenses for 16 years, with the latest figure at -$20221.0 in Q4 2025.
- Quarterly Change in Accured Expenses fell 154.08% year-over-year to -$20221.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6263.0 (up 103.94% YoY) and the FY2025 annual result came in at $6263.0, up 103.94% from the prior year.
- Change in Accured Expenses slipped to -$20221.0 in Q4 2025 per RDGL's latest filing, from $16235.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $176085.0 in Q4 2023 and troughed at -$170238.0 in Q1 2024.
- A 5-year average of $4115.8 and a median of $839.5 in 2021 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 1261.2% in 2022, down 768.76% in 2022.
- Over 5 years, Change in Accured Expenses stood at $11852.0 in 2021, then slumped by 768.76% to -$79261.0 in 2022, then jumped by 322.16% to $176085.0 in 2023, then slumped by 78.77% to $37389.0 in 2024, then tumbled by 154.08% to -$20221.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$20221.0, $16235.0, and -$18920.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | -20,221.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20,221.00 |
| Dec 31, 2025 | -20,221.00 |
| Sep 30, 2025 | 16,235.00 |
| Sep 30, 2025 | 16,235.00 |
| Jun 30, 2025 | -18,920.00 |
| Jun 30, 2025 | -18,920.00 |
| Mar 31, 2025 | 29,169.00 |
| Mar 31, 2025 | 29,169.00 |
| Dec 31, 2024 | 37,389.00 |
| Dec 31, 2024 | 37,389.00 |
| Sep 30, 2024 | -117,740.00 |
| Sep 30, 2024 | -117,740.00 |
| Jun 30, 2024 | 91,794.00 |
| Jun 30, 2024 | 91,794.00 |
| Mar 31, 2024 | -170,238.00 |
| Mar 31, 2024 | -170,238.00 |
| Dec 31, 2023 | 176,085.00 |
| Dec 31, 2023 | 176,085.00 |
| Sep 30, 2023 | -15,441.00 |
| Sep 30, 2023 | -15,441.00 |